OTC · Medical - Devices

Ion Beam Applications S.A. (IOBCF) Stock

$17.93 +0.00% OTC: IOBCF Healthcare

Ion Beam Applications S.A. (IBA) is a company specializing in the design, manufacturing, and ongoing support of sophisticated medical equipment and software solutions primarily focused on treating cancer.

Valuation

MetricValue
Price$17.93
Market Cap$525.85M
P/E Ratio36.50
P/B Ratio3.66
P/S Ratio0.75
EPS (TTM)$0.49
52-Week High$20.10
52-Week Low$11.45
Dividend Yield1.62%

Financials & Margins

MetricValue
ROE10.28%
ROA1.83%
ROCE12.53%
Gross Margin32.18%
Operating Margin4.40%
Net Margin2.04%
Debt/Equity0.92
Current Ratio0.99

Annual Financials (USD)

Metric20212022202320242025
Revenue$313.0M$361.0M$429.0M$498.0M$620.0M
Operating Profit$13.0M$5.0M$5.0M$20.0M$22.0M
Net Profit$4.0M$6.0M$-9.0M$9.0M$13.0M
EPS$0.13$0.20$-0.31$0.31$0.43
Op Margin4.3%1.4%1.2%3.9%3.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$546.0M$624.0M$598.0M$616.0M$690.0M
Total Liabilities$420.0M$508.0M$491.0M$505.0M$563.0M
Cash$199.0M$158.0M$109.0M$72.0M$65.0M
Borrowings$69.0M$41.0M$42.0M$44.0M$117.0M

Latest News

IBA – Regulated information GlobeNewswire · Jul 14, 2026 The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions GlobeNewswire · Jun 30, 2026 IBA to install the first proton therapy center in Brazil in Rio de Janeiro GlobeNewswire · Jun 25, 2026 IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend GlobeNewswire · Jun 17, 2026 IBA strengthens its leadership team to support its growth GlobeNewswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$87.0M$22.0M$-20.0M$-11.0M$-26.0M
Investing Cash Flow$-13.0M$-26.0M$-26.0M$-21.0M$-45.0M
Financing Cash Flow$-18.0M$-11.0M$-1.0M$-5.0M$-12.0M
Net Cash Flow$45.0M$-41.0M$-49.0M$-37.0M$1.0M
Free Cash Flow$82.0M$14.0M$-32.0M$-18.0M$-35.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.84
EV / EBITDA13.79
FCF Yield-7.57%
Quick Ratio0.71
Interest Coverage1.95
Return 1Y24.60%
Return 3Y23.41%
Return 5Y—

Ownership

Insiders Held36.10%
Institutions Held23.90%
Institutions Float Held37.39%
Institutional HolderSharesReport Date
American Century ETF Trust-Avantis International Small Cap Value ETF200,2192026-06-30
DFA INVESTMENT TRUST CO-The Continental Small Company Series101,1132026-04-30
AMG Funds-AMG Yacktman Special Opportunities Fund60,0002026-03-31
WisdomTree Trust-WisdomTree International SmallCap Dividend Fund35,4552026-06-30
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.15,9802026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Ion Beam Applications S.A.

Ion Beam Applications S.A. (IBA) is a company specializing in the design, manufacturing, and ongoing support of sophisticated medical equipment and software solutions primarily focused on treating cancer. Its operations span Belgium, the United States, and various international markets. The company's activities are broadly organized into two main divisions: 1. Proton Therapy and Other Accelerators: This segment is responsible for the engineering, construction, and maintenance of both medical and industrial particle accelerators, including complete proton therapy systems. It also delivers comprehensive, ready-to-use systems for cancer treatment leveraging proton beams. Furthermore, this division produces a variety of cyclotron machines for generating radioisotopes vital for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) imaging, alongside industrial-grade accelerators used in sterilization and ionization processes. 2. Dosimetry: This division offers specialized tools and expert services aimed at enhancing the precision and minimizing errors in radiation oncology treatments, as well as in the quality assurance and calibration protocols for medical imaging systems. IBA actively engages in strategic collaborations, including a key research and development partnership with SCK CEN (the Belgian nuclear research center) focused on enabling the synthesis of Actinium-225 (225Ac), a pioneering radioisotope for cancer therapy. The company also collaborates with the University of Pennsylvania for cutting-edge research into ConformalFLASH technology. Ion Beam Applications S.A. was established in 1986 and maintains its corporate headquarters in Louvain-la-Neuve, Belgium.

Ion Beam Applications S.A. is headquartered in BE.

Ion Beam Applications S.A. (IOBCF) stock trades at $17.93 with a market capitalization of $525.85M. The stock is valued at a price-to-earnings (P/E) ratio of 36.50, price-to-book of 3.66, price-to-sales of 0.75. Over the past 52 weeks the stock has ranged between $11.45 and $20.10, and currently trades 10.8% below its 52-week high. It pays a dividend yielding 1.62%.

On profitability, Ion Beam Applications S.A. generates a return on equity (ROE) of 10.28%, return on capital employed of 12.53%, an operating margin of 4.40%, a net profit margin of 2.04%.

Official website: www.iba-worldwide.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides